Search for content, post, videos

Ted Fjällman is a new board member at XNK Therapeutics

Ted Fjällman
XNK Therapeutics has announced that Ted Fjällman, Partner at Flerie Invest, has joined the company’s board of directors. Flerie Invest led the SEK 132 million financing of XNK earlier this year by placing SEK 100 million and thus gaining approximately 22 percent of the total number of shares a
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.